Home
University of Bergen

Centre for Cancer Biomarkers CCBIO

Collage of photos from CCBIO situations; research, teaching, symposia.

Centre for Cancer Biomarkers (CCBIO) is a Centre of Excellence at the Faculty of Medicine, University of Bergen. 

The center is working on new cancer biomarkers and targeted therapy, and has particular focus on mechanisms that show how cancer cells are affected by the microenvironment in the tumors, and what significance this has for cancer proliferation and poor prognosis. Centre Director is Lars A. Akslen, Department of Clinical Medicine. Read about our research and activities in the CCBIO Annual Report.

Project managers
CCBIO's principal investigators:

CCBIO ACTIVITIES DURING CORONA PERIOD
doctor and text Lets stop the coronavirus together

Corona measures: Impact on CCBIO

CCBIO operates within the health services in addition to the Faculty of Medicine at the UiB and is subject to the guidelines issued by both institutions (see below links). As a consequence, we are reducing our activities accordingly. Please check the calendar for details. Notably, the CCBIO Annual...

News
Collage, Breaking News illustration plus the discussion panel in the auditorium.

Framing cancer

CCBIO recently completed its CCBIO903 course Cancer Research: Ethical, Economic and Social Aspects, including a CCBIO Special Seminar, titled “Cancer in the news”. The course is quite unique on a global basis, and recruited participants with a great variety of backgrounds and of geographical...

Medical Student Research Program
Young researchers in the lab.

Rewarding to have Medical Student Research Program students in the research group

Since CCBIO was established five years ago, 17 students in the Medical Student Research Program have been affiliated to the center's research groups, and several have proceeded to a PhD degree. The students in the program are genuinely interested and dedicated, but also lacking research...

International network
Portrait photo.

Hani Gabra appointed CMO at BerGenBio

Professor Hani Gabra was recently appointed Chief Medical Officer at BerGenBio, based in Oxford UK. Professor Gabra has been part of CCBIO's network of international affiliated researchers since 2016, and considers his affiliation to CCBIO both an advantage and a prerequisite for his role as...

Shortcuts: Read CCBIO's Annual Reports and the CCBIO Newsletter

CCBIO is established in 2013 by the Research Council of Norway in collaboration with the University of Bergen. Other important sources of financial support are Helse Vest and the Norwegian Cancer Society. CCBIO is part of the Research Council of Norway's Centres of Excellence (CoE) scheme. The scheme organizes the activities of Norway’s foremost scientific circles in centres to achieve ambitious scientific objectives through collaboration and long-term basic funding.